<h4>Background</h4>PCSK9 antibodies strongly reduce LDL cholesterol. The effects of PCSK9 antibodies on triglyceride metabolism are less pronounced. The present study aimed to investigate in detail the effects of alirocumab on triglycerides, triglyceride-rich lipoproteins, and lipase regulators.<h4>...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!